Profil
Laura Saward formerly worked at Cangene Corp., as Chief Scientific Officer from 2012 to 2014, Emergent BioSolutions, Inc., as SVP & Antibody Therapeutics Business Unit from 2017 to 2021, and Manitoba Health Research Council, as Member.
Dr. Saward received her undergraduate degree from the University of Guelph and doctorate degree from the University of Manitoba.
Ehemalige bekannte Positionen von Laura Saward
| Unternehmen | Position | Ende |
|---|---|---|
| EMERGENT BIOSOLUTIONS INC. | Corporate Officer/Principal | 01.10.2021 |
| CANGENE CORPORATION | Chief Tech/Sci/R&D Officer | 01.04.2014 |
| Manitoba Health Research Council | Corporate Officer/Principal | - |
Ausbildung von Laura Saward
| University of Guelph | Undergraduate Degree |
| University of Manitoba | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| EMERGENT BIOSOLUTIONS INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Cangene Corp.
 Cangene Corp. Pharmaceuticals: MajorHealth Technology Cangene Corp. developed, manufactured and sold biopharmaceutical drugs. The company was founded on February 22, 1984 and was headquartered in Winnipeg, Canada. | Health Technology |
| Manitoba Health Research Council |
